22
Participants
Start Date
July 31, 1996
Primary Completion Date
August 31, 1996
Study Completion Date
August 31, 1996
YF476
There were 5 treatments: 3 dose levels of YF476 (5, 25 and 100 mg), placebo and ranitidine 150 mg. There were at least 7 days between consecutive Treatment Days.
Ranitidine
There were 5 treatments: 3 dose levels of YF476 (5, 25 and 100mg), placebo and ranitidine 150mg. There were at least 7 days between consecutive Treatment Days.
Hammersmith Medicines Research, London
Collaborators (1)
Ferring Pharmaceuticals
INDUSTRY
Trio Medicines Ltd.
INDUSTRY